Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis?

Nature Clinical Practice Rheumatology

Volumn 2, Issue 2, 2006, Pages 72-73

  Levy Clarke, Grace ^a   Nussenblatt, Robert ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Ankylosing spondylitis; Anti tumor necrosis factor agents; Uveitis

Indexed keywords

CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ACCOMMODATION PARALYSIS; ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; CILIARY BODY; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; EYE INFLAMMATION; FISHER EXACT TEST; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFORMATION RETRIEVAL; IRIDOCYCLITIS; IRIS; MEDLINE; MYDRIASIS; NONHUMAN; OPEN STUDY; OPTIC NEURITIS; PATHOGENESIS; PHOTOPHOBIA; PREVALENCE; PRIORITY JOURNAL; REMISSION; RISK REDUCTION; SHORT SURVEY; SPONDYLOARTHROPATHY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 32644449491     PISSN: 17458382     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncprheum0097     Document Type: Short Survey

References (5)

1. Rosenbaum J et al. (2002) Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 20 (Suppl 28): S67-S70
2. Kim HS et al. (2001) The expression of multiple cytokines and inducible nitric oxide synthase in experimental melanin-protein-induced uveitis. Ophthalmic Res 33: 329-335
3. Lapadula G (2005) Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases. Reumatismo 57 (Suppl 1): 22-29
4. Jabs et al. (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509-516
5. Suhler EB et al. (2005) A prospective trial of infliximab therapy for refractory uveitis. Arch Ophthalmol 123: 903-912